N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study

Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak

(2021) Zhigang Wang et al.   BMC INFECTIOUS DISEASES

On the analysis of mortality risk factors for hospitalized COVID-19 patients: A data-driven study using the major Brazilian database

(2021) Fernanda Sumika Hojo de Souza et al.   PLoS One

COVID-19: consider cytokine storm syndromes and immunosuppression

(2020) Puja Mehta et al.   LANCET

Is the use of ACE inb/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients?

(2020) Murat Selçuk et al.   CLINICAL AND EXPERIMENTAL HYPERTENSION

Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine

(2020) Homam Ibrahim et al.   CLINICAL IMMUNOLOGY

Double-blind, randomized, placebo-controlled trial with N-acetylcysteine for treatment of severe acute respiratory syndrome caused by COVID-19

(2020) Julio Cesar Garcia de Alencar et al.   CLINICAL INFECTIOUS DISEASES

N-acetylcysteine modulates lipopolysaccharide-induced intestinal dysfunction

(2019) Sang In Lee et al.   Scientific Reports

N-acetyl cysteine protects anti-melanoma cytotoxic T cells from exhaustion induced by rapid expansion via the downmodulation of Foxo1 in an Akt-dependent manner

(2018) Matthew J. Scheffel et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia

(2018) Qianwen Zhang et al.   MEDICINE

Effects of N-acetylcysteine treatment in acute respiratory distress syndrome: A meta-analysis

(2017) Ying Zhang et al.   Experimental and Therapeutic Medicine

The anti-inflammatory effects of acetaminophen and N-acetylcysteine through suppression of the NLRP3 inflammasome pathway in LPS-challenged piglet mononuclear phagocytes

(2015) Yu Liu et al.   Innate Immunity

N-acetylcysteine in COPD: why, how, and when?

(2015) Claudio M. Sanguinetti   MULTIDISCIPLINARY RESPIRATORY MEDICINE

N-acetyl-l-cysteine (NAC) inhibit mucin synthesis and pro-inflammatory mediators in alveolar type II epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV)

(2011) Manuel Mata et al.   BIOCHEMICAL PHARMACOLOGY

The Enhancing Effect of the Antioxidant N-Acetylcysteine on Urinary Bladder Injury Induced by Dimethylarsinic Acid

(2011) Naofumi Takahashi et al.   TOXICOLOGIC PATHOLOGY

Interpreting indicators of iron status during an acute phase response – lessons from malaria and human immunodeficiency virus

(2008) Christine A Northrop-Clewes   ANNALS OF CLINICAL BIOCHEMISTRY